Page last updated: 2024-11-05

thioridazine and Hepatolenticular Degeneration

thioridazine has been researched along with Hepatolenticular Degeneration in 1 studies

Thioridazine: A phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA.
thioridazine : A phenothiazine derivative having a methylsulfanyl subsitituent at the 2-position and a (1-methylpiperidin-2-yl)ethyl] group at the N-10 position.

Hepatolenticular Degeneration: A rare autosomal recessive disease characterized by the deposition of copper in the BRAIN; LIVER; CORNEA; and other organs. It is caused by defects in the ATP7B gene encoding copper-transporting ATPase 2 (EC 3.6.3.4), also known as the Wilson disease protein. The overload of copper inevitably leads to progressive liver and neurological dysfunction such as LIVER CIRRHOSIS; TREMOR; ATAXIA and intellectual deterioration. Hepatic dysfunction may precede neurologic dysfunction by several years.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tu, J1

Other Studies

1 other study available for thioridazine and Hepatolenticular Degeneration

ArticleYear
The inadvisability of neuroleptic medication in Wilson's disease.
    Biological psychiatry, 1981, Volume: 16, Issue:10

    Topics: Adult; Antipsychotic Agents; Chlorpromazine; Diagnosis, Differential; Female; Hepatolenticular Degen

1981